The University of Chicago Medicine Comprehensive Cancer Center

Chicago, Illinois 60637

5 studies enrolling now · 6 studies all time

What they study most

Arthritis, Arthropathy, Breast Cancer, Cancer, ER Positive Breast Cancer, Estrogen Receptor Positive Tumor, HER-2 Protein Overexpression, HER2 Low Breast Cancer, HER2 Low Breast Carcinoma, HER2 Mutation-Related Tumors, HER2-negative Breast Cancer, HER2-positive Breast Cancer

Studies at this site

• Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer — Recruiting now
• PRE-I-SPY Phase I/Ib Oncology Platform Program — Recruiting now
• Study to Understand Relationship Between Gut Health and Toxicities of Hormonal Breast Cancer Treatment — Starting soon
• Radiation to Treat Joint Damage Caused by Cancer Immunotherapy — Starting soon
• A Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck — Starting soon
• JTX-2011 Alone and in Combination With Anti-PD-1 or Anti-CTLA-4 in Subjects With Advanced and/or Refractory Solid Tumors — Completed